التفاصيل البيبلوغرافية
| العنوان: |
Alzheimer's disease: Newer biomarkers. |
| المؤلفون: |
Dangi, Ankit1 (AUTHOR), Chatterjee, Kaushik1 (AUTHOR), Banwa, Manjur1 (AUTHOR), Chauhan, Vinay1 (AUTHOR), Yadav, Prateek1 (AUTHOR) |
| المصدر: |
Industrial Psychiatry Journal. 2021 Supplement, Vol. 30, p315-319. 5p. |
| مصطلحات موضوعية: |
ALZHEIMER'S disease, DRUG target, BIOMARKERS, DEMENTIA |
| مصطلحات جغرافية: |
INDIA |
| مستخلص: |
Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%–80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stands at 90%. Attempts have been made to define AD biologically. This has been made possible due to advances in the identification of biomarkers that indicate the neuropathological changes responsible for AD. Identification of these biomarkers has implications for disease staging, prognostication, and identifying drug targets. Here, we summarize the advances in the field of biomarkers in AD. [ABSTRACT FROM AUTHOR] |
|
Copyright of Industrial Psychiatry Journal is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Business Source Index |
Full Text Finder